Lifepoint Health, Eon Release Data Showing Why Identification and Follow-Up of Incidental Findings are Integral to Improving Breast Cancer Diagnosis and Outcomes
Patients identified through incidental findings are 6.2x more likely to be diagnosed with breast cancer compared to screening.